You are here:  > Home Page

From the first issue of Volume 26 (2021) Antiviral Therapy will be published by SAGE Publishing.

Please note that the journal is running later than expected due to COVID-19.

During the transition, you can still access content to which you have subscribed via the AVT website. Content will be available to access via the SAGE Journals platform in Summer 2021. https://uk.sagepub.com/en-gb/eur/antiviraltherapy.

If you have any questions relating to the transfer, please contact journaltransitions@sagepub.com

From the first issue of Volume 26 (2021) Antiviral Therapy will be published by SAGE Publishing.

Subscriptions Please note that Antiviral Therapy is running later than expected due to COVID-19.

All subscription queries should be sent to subscriptions@sagepub.co.uk

Orders via subscription agents
If you are using a subscription agent, please instruct your agent as usual. We are notifying all subscription agents of this change of publisher and they will be able to handle your query.

Pricing enquiries 2021 Antiviral Therapy pricing set by International Medical Press will be honoured.

From the first issue of Volume 26 (2021) Antiviral Therapy will be published by SAGE Publishing.

Please continue to submit your manuscripts to the AVT ScholarOne site (https://mc.manuscriptcentral.com/avt)

For papers already in peer-review, you will be informed of a decision as soon as possible. All accepted papers not assigned to a 2020 issue will now be published by SAGE.

Exploring Connections

Delivering essential care in Neurology: a series of accredited webinars

23rd Virtual Workshop

Register now for International Workshop on Long-term Complications of HIV and SARS-CoV-2.

ASCEND

An international CME-accredited educational initiative in diabetes

global company at the forefront of medical education

International Medical Press specializes in providing peer-reviewed IME and accredited CME activities. Our work is backed by enduring relationships with global faculty, providing strong scientific support across a number of therapy areas. We are a highly qualified team, with extensive experience in medical education and exceptional project management skills.

 
Our portfolio
♦ Tailored projects using cutting-edge technology and interactivities
♦ International workshops and preceptorships bringing leading scientists and clinicians together
♦ Vehicles including e-learning, animation and videocasts – live, online or in print
♦ Pharma Awards EU 2020 winner: Most Valuable Education Initiative and Communiqué 2020 winner: Excellence in Professional Education Programmes

  

Good CME Practice
International Medical Press is a founding partner in the Good CME Practice (gCMEp) Group that is committed to delivering patient-centred, balanced and transparent medical education.

IMP are delighted to support the 14th Annual meeting of the European CME Forum, which as held virtually 3-5 November 2021. https://cmeforum.org




Opening the door on entry inhibitors
Learn about the role of entry inhibitors in the treatment of people with HIV.

 https://www.opendoorhiv.com

Copyright © 2022 Nucleus Holdings Ltd. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.